We are live on ! Find out more
CASC

Cascadian Therapeutics, Inc.
CASC

Delisted

CASC was delisted on the 8th of March, 2018.

Back to rankings

66 hedge funds and large institutions have $44.3M invested in Cascadian Therapeutics, Inc. in 2013 Q2 according to their latest regulatory filings, with 66 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

707% more call options, than puts

Call options by funds: $3.3M | Put options by funds: $409K

Holders
66
Holders Change
+66
Holders Change %
–
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
66
Increased
–
Reduced
–
Closed
–
Calls
$3.3M
Puts
$409K
Net Calls
+$2.89M
Net Calls Change
+$2.89M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
CI
26
Cowen Inc
New York
$259K +$353K +27,500 New
CS
27
Credit Suisse
Switzerland
$250K +$341K +26,560 New
Group One Trading
28
Group One Trading
Illinois
$243K +$334K +25,974 New
Bank of America
29
Bank of America
North Carolina
$192K +$261K +20,317 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$127K +$173K +13,452 New
Barclays
31
Barclays
United Kingdom
$126K +$171K +13,330 New
Nomura Holdings
32
Nomura Holdings
Japan
$111K +$148K +11,497 New
SG Americas Securities
33
SG Americas Securities
New York
$88K +$121K +9,389 New
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$78K +$107K +8,333 New
ProShare Advisors
35
ProShare Advisors
Maryland
$75K +$103K +8,016 New
OAM
36
Oxford Asset Management
United Kingdom
$70K +$96.3K +7,500 New
AIG
37
American International Group
New York
$61.4K +$84.2K +6,558 New
State Board of Administration of Florida Retirement System
38
State Board of Administration of Florida Retirement System
Florida
$59K +$81.2K +6,325 New
FAAS
39
First Allied Advisory Services
California
$57K +$77.1K +6,000 New
Citigroup
40
Citigroup
New York
$54K +$74.4K +5,795 New
HK
41
Horizon Kinetics
New York
$51K +$69.2K +5,389 New
APU
42
Alpine Partners USVI
U.S. Virgin Islands
$46K +$62.8K +4,889 New
Jane Street
43
Jane Street
New York
$46K +$62.9K +4,897 New
State Street
44
State Street
Massachusetts
$46K +$63.5K +4,940 New
Dimensional Fund Advisors
45
Dimensional Fund Advisors
Texas
$45K +$62K +4,823 New
Charles Schwab
46
Charles Schwab
California
$42K +$55K +4,283 New
LTFS
47
Ladenburg Thalmann Financial Services
Florida
$42K +$57.5K +4,480 New
NFA
48
Nationwide Fund Advisors
Ohio
$40K +$54.4K +4,233 New
U
49
UBS
Switzerland
$39K +$53K +4,127 New
KCG
50
Knight Capital Group
$38K +$52.8K +4,113 New
1
2
3

CASC Hedge Fund Activity: Q2 2013 in Review

66 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Cascadian Therapeutics, Inc. (CASC) for Q2 2013, worth a combined $44.3M.

Buyers outnumbered sellers: 66 funds opened new CASC positions and 0 closed out — a net gain of 66 holders — while 0 added to existing stakes and 0 trimmed.

  • 66 institutional investors held Cascadian Therapeutics, Inc. (CASC) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $44.3M of Cascadian Therapeutics, Inc. stock for Q2 2013.
  • 66 funds opened new Cascadian Therapeutics, Inc. positions in Q2 2013 and 0 closed out, a net change of +66 holders.

Based on aggregated 13F filings for Q2 2013.